Literature DB >> 33653418

Pyoderma gangrenosum and cobalamin deficiency in systemic lupus erythematosus: a rare but non fortuitous association.

Sing Chiek Teoh1, Chun Yang Sim2, Seow Lin Chuah3, Victoria Kok1, Cheng Lay Teh3.   

Abstract

BACKGROUND: Pyoderma gangrenosum (PG) is an uncommon, idiopathic, ulcerative neutrophilic dermatosis. In many cases, PG is associated with a wide variety of different disorders but SLE in association with PG is relatively uncommon. In this article we present the case of a middle aged patient with PG as the initial clinical presentation of SLE. We also provide a brief review of cobalamin deficiency which occurred in our patient and evidence-based management options. CASE
PRESENTATION: A 35 years old man presented with a 5 month history of debilitating painful lower limb and scrotal ulcers. This was associated with polyarthralgia and morning stiffness involving both hands. He also complained of swallowing difficulties. He had unintentional weight loss of 10 kg and fatigue. Physical examination revealed alopecia, multiple cervical lymphadenopathies, bilateral parotid gland enlargement and atrophic glossitis. There was Raynaud's phenomenon noted over both hands and generalised hyper-pigmented fragile skin. Laboratory results disclosed anaemia, leukopenia, hyponatraemia and hypocortisolism. Detailed anaemic workup revealed low serum ferritin and cobalamin level. The autoimmune screen showed positive ANA, anti SmD1, anti SS-A/Ro 52, anti SSA/Ro 60, anti U1-snRNP with low complement levels. Upper gastrointestinal endoscopy with biopsies confirmed atrophic gastritis and duodenitis. Intrinsic factor antibodies and anti-tissue transglutaminase IgA were all negative. Punch biopsies of the leg ulcer showed neutrophilic dermatosis consistent with pyoderma gangrenosum. Based on the clinical findings and positive immunologic studies, he was diagnosed as systemic lupus erythematosus. His general condition improved substantially with commencement of corticosteroids, immunosuppressants and vitamin supplements.
CONCLUSIONS: We report a case of PG as the first manifestation of SLE which was treated successfully with immunosuppressants and vitamin supplements. Our report highlighted the need to consider connective tissue diseases such as SLE in a patient presenting with PG in order for appropriate treatment to be instituted thereby achieving a good outcome.

Entities:  

Keywords:  Anaemia; Cobalamin deficiency; Pyoderma gangrenosum (PG); Systemic lupus erythematosus (SLE)

Year:  2021        PMID: 33653418     DOI: 10.1186/s41927-021-00177-4

Source DB:  PubMed          Journal:  BMC Rheumatol        ISSN: 2520-1026


  11 in total

1.  Excellent effect of steroid plus azathioprine in a young woman with pernicious anaemia and systemic lupus erythematosus.

Authors:  Y L Shih; D M Chang
Journal:  Clin Rheumatol       Date:  2000       Impact factor: 2.980

2.  Anaemia in systemic lupus erythematosus: aetiological profile and the role of erythropoietin.

Authors:  M Voulgarelis; S I Kokori; J P Ioannidis; A G Tzioufas; D Kyriaki; H M Moutsopoulos
Journal:  Ann Rheum Dis       Date:  2000-03       Impact factor: 19.103

3.  Skin ulcerations in a lupus hemodialysis patient with hepatitis C infection: what is your diagnosis?

Authors:  Amine Mohamed Hamzi; Abdelali Bahadi; Ahmed Alayoud; Driss El Kabbaj; Mohamed Benyahia
Journal:  Iran J Kidney Dis       Date:  2013-05       Impact factor: 0.892

4.  Pyoderma gangrenosum in a patient with bullous systemic lupus erythematosus.

Authors:  Taiko Sakamoto; Takashi Hashimoto; Fukumi Furukawa
Journal:  Eur J Dermatol       Date:  2002 Sep-Oct       Impact factor: 3.328

5.  Anemia, serum vitamin B12, and folic acid in patients with rheumatoid arthritis, psoriatic arthritis, and systemic lupus erythematosus.

Authors:  Refael Segal; Yehuda Baumoehl; Ori Elkayam; David Levartovsky; Irena Litinsky; Daphna Paran; Irena Wigler; Beni Habot; Arthur Leibovitz; Ben Ami Sela; Dan Caspi
Journal:  Rheumatol Int       Date:  2003-04-29       Impact factor: 2.631

6.  Pyoderma gangrenosum associated with the secondary antiphospholipid syndrome.

Authors:  M H Schmid; C Hary; B Marstaller; B Konz; C M Wendtner
Journal:  Eur J Dermatol       Date:  1998 Jan-Feb       Impact factor: 3.328

7.  Serum cobalamin and transcobalamin levels in systemic lupus erythematosus.

Authors:  Y Molad; B Rachmilewitz; Y Sidi; J Pinkhas; A Weinberger
Journal:  Am J Med       Date:  1990-02       Impact factor: 4.965

Review 8.  Neutrophilic skin lesions in autoimmune connective tissue diseases: nine cases and a literature review.

Authors:  Estelle Hau; Marie-Dominique Vignon Pennamen; Maxime Battistella; Anne Saussine; Maud Bergis; Benedicte Cavelier-Balloy; Michel Janier; Florence Cordoliani; Martine Bagot; Michel Rybojad; Jean-David Bouaziz
Journal:  Medicine (Baltimore)       Date:  2014-12       Impact factor: 1.889

Review 9.  Clinical manifestations of chronic atrophic gastritis.

Authors:  Kryssia Isabel Rodriguez-Castro; Marilisa Franceschi; Antonino Noto; Chiara Miraglia; Antonio Nouvenne; Gioacchino Leandro; Tiziana Meschi; Gian Luigi De' Angelis; Francesco Di Mario
Journal:  Acta Biomed       Date:  2018-12-17

10.  Hematological disorders in patients with systemic lupus erythematosus.

Authors:  Fozya Bashal
Journal:  Open Rheumatol J       Date:  2013-10-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.